Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RPRX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RPRX
Royalty Pharma plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only RPRX
8
BIIB
Biogen
customer
EXEL
Exelixis
customer
DNLI
Denali Therapeutics
supplier
SNDX
Syndax Pharmaceuticals
supplier
Role chip = supplier or customer
Source: SEC EDGAR
4 more · RPRX chain
›
LLY
ELI Lilly & Co
Change
1,418.01
▲
+0.03%
· post 1,412.00
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RPRX
Royalty Pharma plc
Change
67.19
▲
+0.01%
· post 66.62
Closed
Nov 2 '26
Mkt cap
$38.2B
Revenue
$674M
Q2 FY26
Revenue
$2.4B
FY25
vs
Compare
Closed
Nov 2 '26
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
1,418.01
▲
+0.03%
post 1,412.00
Price
67.19
▲
+0.01%
post 66.62
$1.3T
Mkt cap
$38.2B
Q3 FY26
$24.4B
Revenue
$674M
Q2 FY26
FY25
$65.2B
Revenue
$2.4B
FY25
Change
Change
LLY
1,418.01
▲
+0.03%
vs
RPRX
67.19
▲
+0.01%
Closed
Nov 2 '26